Model-informed COVID-19 vaccine prioritization strategies by age and serostatus
모델 기반 COVID-19 백신 우선 순위 지정 전략(나이 및 혈청 상태별)
Research Article
[키워드] accounted
acquired immunity
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Adults
Affect
age
available doses
can be used
Characteristics
Comorbidities
coronavirus
country
COVID-19
COVID-19 vaccine
cumulative
cumulative incidence
death
disease
distribution
dose
doses
effective
Efficacy
estimate
fatality
FIVE
greater
groups
immune
Impact
incidence
individual
individuals
initial
life
Limited
mathematical
mathematical model
Mortality
naturally acquired immunity
Older
Older adults
Perspective
priority
question
raise
reduce
reducing
required
respiratory
risk
risk of death
SARS-CoV-2
Science
serological test
Serological tests
seronegative
serostatus
severe acute respiratory syndrome Coronavirus
susceptibility
the vaccine
those with comorbidities
those with comorbidity
Transmission
transmission rates
vaccinate
vaccination
Vaccine
vaccine efficacy
Variation
[DOI] 10.1126/science.abe6959 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1126/science.abe6959 PMC 바로가기 [Article Type] Research Article